O'Connor, Christopher M <br/><br/>
Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.  [electronic resource] 

 -  JAMA  Sep 2003 
 - 1459-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.290.11.1459  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--therapeutic use<br/>Antibodies, Bacterial--blood<br/>Azithromycin--therapeutic use<br/>Chlamydophila Infections--complications<br/>Chlamydophila pneumoniae--immunology<br/>Coronary Disease--microbiology<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--complications<br/>Proportional Hazards Models